
Leading robotic surgery systems developer Intuitive Surgical Inc. (NASDAQ: ISRG) kicked off the new year by issuing upside guidance for its fourth quarter of 2024. Its da Vinci Surgical System has had a first-mover advantage ever since it launched in 2000, becoming the first commercial robotic surgical platform approved by the FDA. It has maintained its dominance and moat for over two decades in the medical sector, expanding its list of approved procedures for general laparoscopic surgery, which encompasses urology, gynecology, cardiothoracic, and colorectal. Shares hit new all-time highs on the upside guidance.